Back to Market Feed

HADLIMA(CF) 40 MG/0.4 ML SYRINGE

adalimumab-bwwd

$1259.2400per ML

Strength

40 mg/.4mL

Manufacturer

NDC

78206018601

Classification

Brand Biologic

Dosage Form

SOLUTION

Route

SUBCUTANEOUS

Last Updated

4/22/2026

Active Ingredients

Approval Type

Biologic (BLA)

FDA Application

On Market Since

7/1/2023

Pharmacological Classes

Antibodies

Monoclonal

Tumor Necrosis Factor Blocker

Tumor Necrosis Factor Receptor Blocking Activity

Price History

1W

0.0%

1M

+0.0%

3M

-0.1%

6M

+0.0%

1Y

+0.2%

3Y

N/A

5Y

N/A

All

+0.2%

Generic Alternatives

Save up to 50%

1 alternative • Same active ingredient

HADLIMA PUSHTOUCH 40 MG/0.8 ML

78206018401•Organon LLC

Related Drugs

Same classification

INFLECTRA 100 MG VIAL

00069080901•Pfizer Inc.

YUSIMRY(CF) 40 MG/0.8 ML PEN

70114022002•Coherus BioSciences Inc

YUSIMRY(CF) 40 MG/0.8 ML PEN

71288081581•Meitheal Pharmaceuticals Inc.